Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Issues Strattera Public Health Advisory On Suicidal Thinking

This article was originally published in The Pink Sheet Daily

Executive Summary

Advisory alerts physicians to the risk of suicidal thinking in children and adolescents related to use of Eli Lilly's ADHD therapy atomoxetine.

You may also be interested in...



ADHD Drug Prescription Trends Are Determined By Side Effect Profile, Study Finds

Study in Journal of Managed Care Pharmacy finds more patients are prescribed atomoxetine when they have psychiatric conditions that could be exaggerated by stimulants.

ADHD Drug Prescription Trends Are Determined By Side Effect Profile, Study Finds

Study in Journal of Managed Care Pharmacy finds more patients are prescribed atomoxetine when they have psychiatric conditions that could be exaggerated by stimulants.

Grassley Mows Down FDA Handling Of ADHD Drug Safety

Adverse events need a “comprehensive review,” Senate Finance Committee Chairman says, questioning FDA’s approach to advisory committees.

Related Content

Topics

UsernamePublicRestriction

Register

PS062970

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel